Stockreport

CytoMed Therapeutics’ Chairman Increases Effective Holdings to 21.95%

CytoMed Therapeutics Limited - Ordinary Shares  (GDTC) 
PDF SINGAPORE, Oct. 22, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical c [Read more]